Diffuse alveolar hemorrhage: Difference between revisions

Line 13: Line 13:


Idiopathic small vessel vasculitis
Idiopathic small vessel vasculitis
* Wegener's granulomatosis
* [[Wegener's granulomatosis]]
* Churg-Straus syndrome
* Churg-Straus syndrome
* Microscopic polyangitis
* Microscopic polyangitis
Line 19: Line 19:
Primary immune complex-mediated vasculitis
Primary immune complex-mediated vasculitis
* Goodpasture's syndrome
* Goodpasture's syndrome
* Henoch-Schonlein purpura
* [[Henoch-Schonlein purpura]]


Secondary vasculitis
Secondary vasculitis
* Systemic lupus erythematosus
* [[Systemic lupus erythematosus]]
* Rheumatoid arthritis
* [[Rheumatoid arthritis]]
* Mixed connective tissue disease
* Mixed connective tissue disease
* Polymyositis/Dermatomyositis
* [[Polymyositis]]/[[Dermatomyositis]]


Acute lung transplant rejection<br />
Acute [[lung transplant]] rejection<br />


Drug induced (ie. chemotherapy, amiodarone, propylthiouracil)<br />
Drug induced (ie. chemotherapy, [[amiodarone]], propylthiouracil)<br />


ARDS<br />
[[ARDS]]<br />


Coagulopathy<br />
[[Coagulopathy]]<br />


Pulmonic veno-occlusive disease <br />
Pulmonic veno-occlusive disease <br />


Mitral stenosis
[[Mitral stenosis]]


===Diagnosis===
===Diagnosis===

Revision as of 16:39, 13 June 2016

Background

  • Diffuse Alveolar Hemorrhage (DAH) is a life-threatening condition.
  • It is a subset of Pulmonary hemorrhage involving the microcirculation involving alveolar microvasculature.
  • Most commonly the result of systemic vasculitis. [1]

Clinical Features

  • Hemoptysis
  • Anemia
  • Diffuse lung infiltrates
  • Acute respiratory failure

Differential Diagnosis

Idiopathic small vessel vasculitis

Primary immune complex-mediated vasculitis

Secondary vasculitis

Acute lung transplant rejection

Drug induced (ie. chemotherapy, amiodarone, propylthiouracil)

ARDS

Coagulopathy

Pulmonic veno-occlusive disease

Mitral stenosis

Diagnosis

Management

General principles

  • Airway stabilization if large volume hemoptysis or problems with oxygenation/ventilation (>8.0 ETT preferable)
  • IV corticosteroids - high dose Methylprednisolone Q6H[2]
  • Bronchoscopy to obtain BAL and localize source of bleeding if localizable
  • Management of Hemoptysis

Disposition

  1. Park M. Diffuse Alveolar Hemorrhage. Tuberc Resp Dis (Seoul) 2013. 74(4):151-162
  2. Park M. Diffuse Alveolar Hemorrhage. Tuberc Resp Dis (Seoul) 2013. 74(4):151-162